Delivery Order SPE2DB20D3103-SPE2DB22FL8Z2
- Not listed
- This federal contract award is for the delivery of Malarone 250-100 mg tablet 100s to the Defense Logistics Agency (DLA). The $3,907.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Malarone 250/100 100s medication. The contract has a ceiling value of $12,088.44 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The award is a firm fixed price delivery order for Malarone 250-100 mg tablets, with a ceiling value of $1,968.67 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Malarone 250-100 mg tablets in quantities of 100 units. This non-set-aside contract is valued at $26,388.91 and carries a firm fixed price structure, with an ultimate completion date of December 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,176.41 firm fixed-price delivery order is for the supply of MALARONE 62.5-25 MG PED TAB 100S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $7,755.83. This firm fixed price delivery order, with an ultimate completion date of December 17, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- This federal contract award is a delivery order valued at $5,676.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MALARONE 250/100 100S, a pharmaceutical product, with a completion date of February 13, 2024. The contract type is firm fixed price, and no set-aside designation was used. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Malarone 250/100 100S pharmaceutical products to the Department of Defense. The $11,352.00 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery...
- This contract award is for the delivery of medical supplies, specifically MALARONE 250/100 100S, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price of $83,096.53 and a performance period ending on February 21, 2019. It was awarded on January 24, 2019 and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $88,409.51, is for the delivery of Malarone 250/100 100S tablets, a pharmaceutical product used for malaria prevention and treatment. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL8Z2Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Malarone 250-100 mg tablets. The contract is a Delivery Order (DO) worth $2,454.40 with a completion date of December 8, 2021. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/7/21 |